6XC1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Soleno Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.156 EUR -0.64% Market Closed

Market Cap: €18.7m

S	Soleno Therapeutics Inc F:6XC1	US
A	Amper SA XMUN:APR	ES
	Smurfit WestRock PLC NYSE:SW	IE
	Pieris Pharmaceuticals Inc F:PI6	US
S	SM Energy Co F:SJL	US
A	Acea SpA SWB:DCA	IT
C	Cohen & Steers Inc F:FG9	US
T	TC Energy Corp XMUN:TRS	CA

Profitability Summary

Soleno Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

99%

Strong 3Y Average Gross Margin

98%

Exceptional Operating Margin

30%

Negative 3Y Average Operating Margin

-160%

Exceptional Net Margin

34%

Negative 3Y Average Net Margin

-147%

Exceptional Free Cash Flow Margin

37%

Negative 3Y Average Free Cash Flow Margin

-56%

Exceptional ROE

26%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-462%

ROIC is Increasing

-313% > 46%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.